Thank you, Rick and good afternoon everyone. Thank you for joining us today. Total revenue for the third quarter of 2024 was $9.4 million, compared with revenue of $9.3 million in the same quarter last year an increase of 1.6%. Our total revenue is made up of two components: franchise royalties which is our primary source of revenue and service revenue which is generated from certain services and interest charged to our franchisees as well as other miscellaneous revenue. Franchise royalties for the third quarter were $9 million, compared to $8.9 million for the same quarter last year. Underlying the royalties are system-wide sales which are not part of our revenue but are a helpful contextual performance indicator. System-wide sales reflect sales at all offices including those classified as discontinued. System-wide sales for the third quarter were $148.6 million, compared to $151.2 million for the same period in 2023. The decrease in system-wide sales was primarily driven by a decline in our professional recruiting and staffing brands of $6.5 million and partially offset by a $3.9 million increase in sales generated by our temporary staffing brands when compared to the prior year period. Service revenue was $428,000 for the third quarter, compared to $366,000 for the same quarter a year ago. Service revenue is composed of interest charged to our franchisees on overdue accounts receivable service fees, other miscellaneous revenue and MRI Networks advertising fund revenue. Service revenue can fluctuate from quarter-to-quarter based on a number of factors including changes in system-wide sales, accounts receivable, insurance renewals and similar dynamics. Selling general and administrative expenses for the third quarter were $5.4 million, compared to $6.4 million in the prior year period, a decrease of 15.3% as the changes we made to our workers' compensation insurance policy in Q1 of this year have lessened the increase in related experience -- excuse me, expense we experienced in 2023. Additionally, we continue to prioritize expense management across our business. Net workers' compensation expense in the third quarter of 2024, was approximately $499,000 compared to a net expense of approximately $1.5 million in the third quarter of 2023. Also included in our SG&A, were salaries and benefits which continues to be the largest component of our operating expenses. In the third quarter of 2024 we recognized $2.8 million in compensation-related expenses, compared to $2.9 million in the third quarter of 2023. Our year-to-date compensation-related expenses decreased 11.1% to $8.5 million, primarily driven by headcount reductions we made during 2023 related to the integration of the MRI Network acquisition. Net loss after-tax was $2.2 million in the third quarter of 2024 or a loss of $0.16 per diluted share compared to a net income of $1.5 million or earnings per diluted share of $0.11 in the third quarter of 2023. As Rick mentioned in his prepared remarks, we recognized, a one-time non-cash impairment charge of $6 million in the quarter related to the MRI network assets we acquired in December 2022. This non-cash impairment charge had a considerable impact on our profitability both in the quarter and year-to-date in 2024. As such, we decided that providing an adjusted net income figure for the quarter and the year-to-date period as of September 30 2024 would be a helpful metric to better showcase the growth and progress that we've achieved. With that said, adjusted net income for the third quarter of 2024 which excludes the one-time non-cash impairment charge, amortization of acquired intangibles and other non-recurring one-time expenses net of the tax effect from these adjustments was $2.8 million or $0.20 per diluted share compared to adjusted net income of $2.2 million or $0.16 per diluted share in the third quarter of 2023. Adjusted net income for the nine months ended September 30, 2024, was $7.3 million or $0.52 per diluted share compared to adjusted net income of $7.3 million or $0.53 per diluted share in the prior year period. We did provide a table in the press release we put out earlier this afternoon with a detailed reconciliation of net income to adjusted net income. Adjusted EBITDA in the third quarter of 2024 was $4.9 million compared to $3.7 million in the prior year period. Adjusted EBITDA margin for the quarter was 52% compared to 40% in the prior year period. We believe adjusted EBITDA is a relevant metric for us due to the size of non-cash operating expenses running through our P&L. A detailed reconciliation of net income to adjusted EBITDA is provided in our press release and our 10-Q. Moving now to the balance sheet. Our current assets at September 30, 2024, were $58 million compared to $51.5 million at December 31, 2023. Current assets as of September 30, 2024, included $1.6 million in cash and $50.5 million of net accounts receivable, while current assets at December 31, 2023, included $1.3 million of cash and $44.4 million of net accounts receivable. Current assets exceeded current liabilities by $23.4 million at September 30, 2024, versus year-end 2023 when working capital was $15.7 million. Current liabilities were 59.7% of current assets at September 30, 2024, versus 69.4% of current assets at December 31, 2023. At September 30, 2024, we had $13.4 million drawn on our credit facility and another $26.9 million in availability assuming continued covenant compliance. Importantly, our credit facility was not impacted by the one-time non-cash impairment charge that we recognized in the quarter. We believe our credit facility provides us with flexibility and room for short-term working capital needs as well as the capacity to capitalize on potential acquisitions. We have paid a regular quarterly dividend since the third quarter of 2020. Most recently, we paid a $0.06 per common share dividend on September 16, 2024, to shareholders of record as of September 2. We expect to continue to pay a dividend each quarter, subject to the Board's discretion. With that, I'll turn the call back over to Rick for some closing comments.